Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis

BACKGROUND: Proton pump inhibitors (PPIs) are widely prescribed, often without clear indications. There are conflicting data on its association with mortality risk and hepatic decompensation in cirrhotic patients. Furthermore, PPI users and PPI exposure in some studies have been poorly defined with...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:World J Gastroenterol
Egile Nagusiak: De Roza, Marianne Anastasia, Kai, Lim, Kam, Jia Wen, Chan, Yiong Huak, Kwek, Andrew, Ang, Tiing Leong, Hsiang, John Chen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Baishideng Publishing Group Inc 2019
Gaiak:
Retrospective Cohort Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737311/
https://ncbi.nlm.nih.gov/pubmed/31543684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i33.4933
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak